Summary
Updated Aug 31, 2026
Karen Jean Ferrante files SEC Form 4 reports at Cogent Biosciences, Inc. (COGT). 9 SEC Form 4 filings on record going back to 2024, most recently on 6 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Karen Jean Ferrante has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Karen Jean Ferrante files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M of COGT open-market activity in the last 12 months
- John Edward Robinson - $3.49M of COGT open-market activity in the last 12 months
- Jessica Sachs - $3.20M of COGT open-market activity in the last 12 months
- John L. Green - $2.98M of COGT open-market activity in the last 12 months
- Evan Kearns - $2.52M of COGT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Karen Jean Ferrante?
Karen Jean Ferrante is a corporate insider of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Karen Jean Ferrante submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Karen Jean Ferrante's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Karen Jean Ferrante and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
